Viridian Therapeutics, Inc.\DE (VRDN) Inventory Average (2014 - 2016)
Viridian Therapeutics, Inc.\DE (VRDN) posted quarterly Inventory Average of $63000.0 for Q4 2016, down 77.13% year-over-year from $275500.0 in Q1 2016, and down 54.18% quarter-over-quarter from $137500.0 in Q3 2016.
Viridian Therapeutics, Inc.\DE (VRDN) Inventory Average (2014 - 2016) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Inventory Average history runs 3 years deep, the most recent figure standing at $63000.0 for Q4 2016.
- In Q4 2016, Inventory Average fell 77.13% year-over-year to $63000.0; the TTM figure through Dec 2016 stood at $63000.0 (down 77.13% YoY), while the FY2016 annual figure was $125500.0, down 31.42% from the prior year.
- Inventory Average for Q4 2016 stood at $63000.0, down from $137500.0 in the prior quarter.
- The five-year high for Inventory Average was $450000.0 in Q3 2015, with the low at $63000.0 in Q4 2016.
- The 3-year median for Inventory Average is $234500.0 (2016), against an average of $250063.4.
- The sharpest annual moves came in 2015 and 2016: Inventory Average soared 111.66% in 2015, then tumbled 77.13% in 2016.
- Viridian Therapeutics, Inc.\DE's Inventory Average stood at $205532.0 in 2014, then jumped by 34.04% to $275500.0 in 2015, then sank by 77.13% to $63000.0 in 2016.
- Business Quant data shows VRDN's Inventory Average at $63000.0 in Q4 2016, $137500.0 in Q3 2016, and $241000.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.50 Bn | 2.50 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 63,000.00 |
| Sep 30, 2016 | 137,500.00 |
| Jun 30, 2016 | 241,000.00 |
| Mar 31, 2016 | 228,000.00 |
| Dec 31, 2015 | 275,500.00 |
| Sep 30, 2015 | 450,000.00 |
| Jun 30, 2015 | 433,000.00 |
| Mar 31, 2015 | 254,500.00 |
| Dec 31, 2014 | 205,532.00 |
| Sep 30, 2014 | 212,602.00 |